Preferences of lung cancer patients for treatment and decision-making: a systematic literature review

Publikation: Beitrag in FachzeitschriftÜbersichtsarbeitForschungPeer-Review

Autoren

  • K. Schmidt
  • K. Damm
  • A. Prenzler
  • H. Golpon
  • T. Welte

Externe Organisationen

  • Medizinische Hochschule Hannover (MHH)
  • Biomedical Research in Endstage & Obstructive Lung Disease (BREATH)
  • Deutsches Zentrum für Lungenforschung (DZL)
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)580-591
Seitenumfang12
FachzeitschriftEuropean Journal of Cancer Care
Jahrgang25
Ausgabenummer4
PublikationsstatusVeröffentlicht - 27 Juni 2016

Abstract

The consideration of patient preferences in decision-making has become more important, especially for life-threatening diseases such as lung cancer. This paper aims to identify the preferences of lung cancer patients with regard to their treatment and involvement in the decision-making process. We conducted a systematic literature review from 12 electronic databases and included studies published between 2000 and 2012. A total of 20 studies were included in this review. These revealed that lung cancer patients do have preferences that should be considered in treatment decisions; however, these preferences are not homogenous. We found that patients often consider life extension to be more important than the health-related quality of life or undesirable side effects. This preference seems to depend on patient age. Nausea and vomiting are the most important side effects to be avoided; the relevance of other side effects differs highly between subgroups. The majority of lung cancer patients, nevertheless, seem to prefer a passive rather than an active role in decision-making, although the self-reported preferences differed partly from the physicians' perceptions. Overall, we identified an urgent need for larger studies that are suitable for subgroup analyses and incorporate multi-attributive measurement techniques.

ASJC Scopus Sachgebiete

Ziele für nachhaltige Entwicklung

Zitieren

Preferences of lung cancer patients for treatment and decision-making: a systematic literature review. / Schmidt, K.; Damm, K.; Prenzler, A. et al.
in: European Journal of Cancer Care, Jahrgang 25, Nr. 4, 27.06.2016, S. 580-591.

Publikation: Beitrag in FachzeitschriftÜbersichtsarbeitForschungPeer-Review

Schmidt K, Damm K, Prenzler A, Golpon H, Welte T. Preferences of lung cancer patients for treatment and decision-making: a systematic literature review. European Journal of Cancer Care. 2016 Jun 27;25(4):580-591. doi: 10.1111/ecc.12425
Schmidt, K. ; Damm, K. ; Prenzler, A. et al. / Preferences of lung cancer patients for treatment and decision-making : a systematic literature review. in: European Journal of Cancer Care. 2016 ; Jahrgang 25, Nr. 4. S. 580-591.
Download
@article{88877dc79c3144389e6d0162d32a5b32,
title = "Preferences of lung cancer patients for treatment and decision-making: a systematic literature review",
abstract = "The consideration of patient preferences in decision-making has become more important, especially for life-threatening diseases such as lung cancer. This paper aims to identify the preferences of lung cancer patients with regard to their treatment and involvement in the decision-making process. We conducted a systematic literature review from 12 electronic databases and included studies published between 2000 and 2012. A total of 20 studies were included in this review. These revealed that lung cancer patients do have preferences that should be considered in treatment decisions; however, these preferences are not homogenous. We found that patients often consider life extension to be more important than the health-related quality of life or undesirable side effects. This preference seems to depend on patient age. Nausea and vomiting are the most important side effects to be avoided; the relevance of other side effects differs highly between subgroups. The majority of lung cancer patients, nevertheless, seem to prefer a passive rather than an active role in decision-making, although the self-reported preferences differed partly from the physicians' perceptions. Overall, we identified an urgent need for larger studies that are suitable for subgroup analyses and incorporate multi-attributive measurement techniques. ",
keywords = "decision-making, lung cancer, patient, preference, systematic review, treatment",
author = "K. Schmidt and K. Damm and A. Prenzler and H. Golpon and T. Welte",
note = "The project was funded by the Federal Ministry of Education and Research.",
year = "2016",
month = jun,
day = "27",
doi = "10.1111/ecc.12425",
language = "English",
volume = "25",
pages = "580--591",
journal = "European Journal of Cancer Care",
issn = "0961-5423",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",

}

Download

TY - JOUR

T1 - Preferences of lung cancer patients for treatment and decision-making

T2 - a systematic literature review

AU - Schmidt, K.

AU - Damm, K.

AU - Prenzler, A.

AU - Golpon, H.

AU - Welte, T.

N1 - The project was funded by the Federal Ministry of Education and Research.

PY - 2016/6/27

Y1 - 2016/6/27

N2 - The consideration of patient preferences in decision-making has become more important, especially for life-threatening diseases such as lung cancer. This paper aims to identify the preferences of lung cancer patients with regard to their treatment and involvement in the decision-making process. We conducted a systematic literature review from 12 electronic databases and included studies published between 2000 and 2012. A total of 20 studies were included in this review. These revealed that lung cancer patients do have preferences that should be considered in treatment decisions; however, these preferences are not homogenous. We found that patients often consider life extension to be more important than the health-related quality of life or undesirable side effects. This preference seems to depend on patient age. Nausea and vomiting are the most important side effects to be avoided; the relevance of other side effects differs highly between subgroups. The majority of lung cancer patients, nevertheless, seem to prefer a passive rather than an active role in decision-making, although the self-reported preferences differed partly from the physicians' perceptions. Overall, we identified an urgent need for larger studies that are suitable for subgroup analyses and incorporate multi-attributive measurement techniques.

AB - The consideration of patient preferences in decision-making has become more important, especially for life-threatening diseases such as lung cancer. This paper aims to identify the preferences of lung cancer patients with regard to their treatment and involvement in the decision-making process. We conducted a systematic literature review from 12 electronic databases and included studies published between 2000 and 2012. A total of 20 studies were included in this review. These revealed that lung cancer patients do have preferences that should be considered in treatment decisions; however, these preferences are not homogenous. We found that patients often consider life extension to be more important than the health-related quality of life or undesirable side effects. This preference seems to depend on patient age. Nausea and vomiting are the most important side effects to be avoided; the relevance of other side effects differs highly between subgroups. The majority of lung cancer patients, nevertheless, seem to prefer a passive rather than an active role in decision-making, although the self-reported preferences differed partly from the physicians' perceptions. Overall, we identified an urgent need for larger studies that are suitable for subgroup analyses and incorporate multi-attributive measurement techniques.

KW - decision-making

KW - lung cancer

KW - patient

KW - preference

KW - systematic review

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85027952954&partnerID=8YFLogxK

U2 - 10.1111/ecc.12425

DO - 10.1111/ecc.12425

M3 - Review article

C2 - 26676876

AN - SCOPUS:85027952954

VL - 25

SP - 580

EP - 591

JO - European Journal of Cancer Care

JF - European Journal of Cancer Care

SN - 0961-5423

IS - 4

ER -